Akshay Kedari holds a graduate degree in computer engineering, however, he turned toward the writing domain to pursue his passion for the art. Presently, Akshay writes news pieces for newsgrazing.com and a few other sites. Additionally, he also boasts of experience as a programmer. He can be contacted at- [email protected] | https://twitter.com/axeyked
Proof of reduced gut permeability with larazotide against the backdrop of diet-induced obesity creates the prospect of controlling the outcomes of metabolic syndrome such as NASH. Innovate Biopharmaceuticals, Inc., the clinical stage biotechnology company, recently announced that it will be presenting proof-of-concept regarding a model …
Philadelphia-based VSBLTY Groupe Technologies Corp. has reportedly declared that it has established a partnership with Muller Group International (MGI). With this alliance, VSBLTY has officially joined the portfolio of MGI partner companies that specialize in providing turnkey security solutions to sports venues, schools, corporations, and …
Globally reputed point-of-care diagnostics company, Chembio Diagnostics, Inc., has apparently declared that Brazil’s health regulatory agency, ANVISA (Agência Nacional de Vigilância Sanitária), in collaboration with Bio-Manguinhos/Fiocruz, has approved its DPP Zika/Dengue/Chikungunya System. Speaking on the disease detection scenario in Brazil, John Sperzel, CEO, Chembio, stated …
The facility will help the pharmaceutical industry of UK, as it will prove ideal for speeding up the development of robust processes and potentially reduce development timelines The Centre for Process Innovation (CPI) has reportedly announced a collaboration with major pharmaceutical players AstraZeneca and GSK …
With the proposed acquisition, Merck intends to expand its presence across the semiconductor materials market The leading U.S.-based electronic materials company, Versum Materials Inc., has reportedly accepted a higher $6.5 billion takeover bid by the Merck Group, the German multinational pharmaceutical company. Reliable reports claim …
Genkyotex, a biopharmaceutical firm and recognized provider of NOX therapies, has recently declared that it will demonstrate an update on the formerly reported interim efficacy results from its Phase two GKT831 clinical trial in patients with Primary Biliary Cholangitis during the 2019 EASL International Liver …
Myriad intends to file an additional premarket approval application with U.S. Food and Drug Administration (FDA) for BRACAnalysis Myriad Genetics, Inc., an American molecular diagnostic company, has announced that it has expanded its companion diagnostic partnership with Merck and AstraZeneca. Under the partnership, the firms will reportedly …
Oxurion NV, a biopharmaceutical firm engaged in creating pioneering treatments to protect vision in people affected by diabetic eye ailment, has reportedly declared that candidates have been registered in its Phase two clinical trial assessing its THR-317. Incidentally, this is a humanized antibody effective against …
On the closing of the deal, the acquisition price is likely to be paid in cash, using funds from the existing credit facilities of FTG. The FTG (Firan Technology Group) Corporation, has reportedly signed a definitive agreement in a bid to acquire a U.S.-based circuit …